Nasal Congestion News and Research

RSS

Oral host responses to SARS-CoV-2 predict progression of COVID-19

In a recent study posted to the medRxiv* preprint server, researchers at the University of North Carolina and the National Institutes of Health determined the associations between oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), oral antibodies against SARS-CoV-2, and coronavirus disease 2019 (COVID-19) symptoms.

14 Mar 2023

Summarizing the evidence of respiratory transmission of mpox

A recent study published in The Lancet Microbe summarized the evidence for respiratory transmission of mpox (formerly monkeypox).

13 Mar 2023

Study shows COVID-19 rates were likely forty-times higher than CDC estimates during BA.4/BA.5 dominant period in the U.S.

Researchers evaluate the prevalence of SARS-CoV-2 infections and the incidence of long COVID during BA.4/BA.5 dominant period.

27 Feb 2023

Rebounding of COVID-19 symptoms and viral load are common among untreated COVID-19 patients

Researchers characterize COVID-19 symptom and viral load rebounds among untreated individuals with mild-to-moderate SARS-CoV-2 infection.

27 Feb 2023

Large study on post-COVID dysosmia and dysgeusia

In a new study posted to the medRxiv* preprint server, scientists in the United States assessed the extent of post-COVID-19 olfactory and gustatory dysfunction to gain deeper insights into the quality and severity of the symptoms over a year.

6 Feb 2023

What older Americans need to know about taking Paxlovid

A new coronavirus variant is circulating, the most transmissible one yet. Hospitalizations of infected patients are rising. And older adults represent nearly 90% of U.S. deaths from covid-19 in recent months, the largest portion since the start of the pandemic.

18 Jan 2023

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Persistent COVID-19 symptoms among South Africans infected during SARS-CoV-2 Beta, Delta and Omicron variant waves

Researchers longitudinally followed up hospitalized (H) and non-hospitalized (NH) COVID-19 patients for six months after laboratory-confirmed SARS-CoV-2 infections to identify factors that increase the risk of post-COVID-19 condition development in the South African population.

4 Nov 2022

FebriDX point-of-care immunoassay can rapidly determine if an infection is bacterial or viral

Researchers explore whether FebriDx could differentiate between bacteria- and virus-induced immune responses during acute respiratory infection.

23 Oct 2022

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

Findings of a new study depicted that fully vaccinated patients suffering from systemic autoimmune rheumatic diseases harbor a lower propensity to developing long COVID symptoms compared to SARDs patients who are not fully vaccinated.

11 Oct 2022

The extent of long COVID and its characteristics among the older population

Researchers explored the characteristics of long COVID among older adults.

5 Oct 2022

What is the effect of the Omicron variant on olfaction?

A new study discusses the effect of the Omicron variant of the virus on the olfactory system in humans.

15 Sep 2022

Saline nasal irrigation after COVID-19 diagnosis reduces hospitalization

Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution soon after testing positive for COVID-19 can significantly reduce hospitalization and death, investigators report.

13 Sep 2022

Globalization and cessation of smallpox vaccination are influencing monkeypox spread

A recent review by Barbara S. Schnierle of the Paul-Ehrlich-Institut, Germany, and published in the journal Viruses summarized the existing knowledge about MPXV, the disease it causes, and the strategies to curb its spread.

1 Sep 2022

Case report on the post-orgasmic illness treated with antihistamines

Scientists discuss a post-orgasmic illness syndrome patient’s experience of being treated with an antihistamine.

23 Aug 2022

Investigating the missing link between COVID-19 and anosmia

A new study evaluated how SARS-CoV-2 infection leads to anosmia via chromatin structure disruption and OR dysregulation. For this purpose, publicly available Hi-C data of OSNs of SARS-CoV-2-infected and control human subjects were used.

23 Aug 2022

The symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2

Researchers evaluated the symptoms and quality of life among individuals with post-acute sequelae of SARS-CoV-2 or PASC.

15 Aug 2022

Doctors discover genetic and viral causes of adenoid hypertrophy in kids

RUDN doctors have discovered genetic and viral causes of a frequent ENT disease in children - adenoid hypertrophy. The results are published in Life.

11 Aug 2022

Fatigue and headache among the most common symptoms following COVID-19 infections

Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.

8 Aug 2022

COVID-19-induced non-cell-autonomous anosmia

Researchers reported that SARS-CoV-2-induced anosmia was based on non-cell-independent processes.

11 May 2022